{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:27Z","timestamp":1787032827805,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,21]]},"DOI":"10.7759\/cureus.82675","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T05:45:11Z","timestamp":1745214311000},"source":"Crossref","is-referenced-by-count":1,"title":["Bone Mineral Density and Bone Quality Trends in a Child on Steroid Therapy Who Developed a Vertebral Fracture: A Case Report"],"prefix":"10.7759","author":[{"given":"Jun","family":"Aoyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takane","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02092-7","article-title":"The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Sch\u00f6nlein purpura nephritis: a meta-analysis","volume":"51","author":"Tan J","year":"2019","unstructured":"Tan J, Tang Y, Zhong Z, Yan S, Tan L, Tarun P, Qin W. The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch-Sch\u00f6nlein purpura nephritis: a meta-analysis. Int Urol Nephrol. 2019, 51:975-85. 10.1007\/s11255-019-02092-7","journal-title":"Int Urol Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.08.019","article-title":"Steroid-associated side effects in patients with primary proteinuric kidney disease","volume":"4","author":"Oh GJ","year":"2019","unstructured":"Oh GJ, Waldo A, Paez-Cruz F, et al.. Steroid-associated side effects in patients with primary proteinuric kidney disease. Kidney Int Rep. 2019, 4:1608-16. 10.1016\/j.ekir.2019.08.019","journal-title":"Kidney Int Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/080352501317061512","article-title":"Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome","volume":"90","author":"Esbj\u00f6rner E","year":"2001","unstructured":"Esbj\u00f6rner E, Arvidsson B, Jones IL, Palm\u00e9r M. Bone mineral content and collagen metabolites in children receiving steroid treatment for nephrotic syndrome. Acta Paediatr. 2001, 90:1127-30. 10.1080\/080352501317061512","journal-title":"Acta Paediatr"},{"key":"ref4","article-title":"Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome","volume":"61","author":"Ko\u015fan C","year":"2012","unstructured":"Ko\u015fan C, Ayar G, Orbak Z. Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome. West Indian Med J. 2012, 61:627-30.","journal-title":"West Indian Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1785","article-title":"Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome","volume":"28","author":"Tsampalieros A","year":"2013","unstructured":"Tsampalieros A, Gupta P, Denburg MR, et al.. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res. 2013, 28:480-8. 10.1002\/jbmr.1785","journal-title":"J Bone Miner Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13832","article-title":"Glucocorticoid effects on bone strength in children with renal diseases","volume":"26","author":"Aoyagi J","year":"2021","unstructured":"Aoyagi J, Kanai T, Ito T, et al.. Glucocorticoid effects on bone strength in children with renal diseases. Nephrology (Carlton). 2021, 26:119-25. 10.1111\/nep.13832","journal-title":"Nephrology (Carlton)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","unstructured":"Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001, 285.785-95. 10.1001\/jama.285.6.785","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.08.012","article-title":"Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition)","volume":"498","author":"Nishizawa Y","year":"2019","unstructured":"Nishizawa Y, Miura M, Ichimura S, et al.. Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition). Clin Chim Acta. 2019, 498:101-7. 10.1016\/j.cca.2019.08.012","journal-title":"Clin Chim Acta"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1652-5","article-title":"Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome","volume":"26","author":"Sbrocchi AM","year":"2011","unstructured":"Sbrocchi AM, Rauch F, Matzinger M, Feber J, Ward LM. Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome. Pediatr Nephrol. 2011, 26:139-42. 10.1007\/s00467-010-1652-5","journal-title":"Pediatr Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2895-8_8","article-title":"Glucocorticoid-induced osteoporosis","volume":"872","author":"Frenkel B","year":"2015","unstructured":"Frenkel B, White W, Tuckermann J. Glucocorticoid-induced osteoporosis. Adv Exp Med Biol. 2015, 872:179-215. 10.1007\/978-1-4939-2895-8_8","journal-title":"Adv Exp Med Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4206","article-title":"Level of serum undercarboxylated osteocalcin correlates with bone quality assessed by calcaneal quantitative ultrasound sonometry in young Japanese females","volume":"13","author":"Suzuki Y","year":"2017","unstructured":"Suzuki Y, Maruyama-Nagao A, Sakuraba K, Kawai S. Level of serum undercarboxylated osteocalcin correlates with bone quality assessed by calcaneal quantitative ultrasound sonometry in young Japanese females. Exp Ther Med. 2017, 13:1937-43. 10.3892\/etm.2017.4206","journal-title":"Exp Ther Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.3.3805","article-title":"Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study","volume":"82","author":"Vergnaud P","year":"1997","unstructured":"Vergnaud P, Garnero P, Meunier PJ, Br\u00e9art G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab. 1997, 82:719-24. 10.1210\/jcem.82.3.3805","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1537-6","article-title":"Biochemical bone markers in nephrotic children","volume":"19","author":"Biyikli NK","year":"2004","unstructured":"Biyikli NK, Emre S, Sirin A, Bilge I. Biochemical bone markers in nephrotic children. Pediatr Nephrol. 2004, 19:869-73. 10.1007\/s00467-004-1537-6","journal-title":"Pediatr Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone HG","year":"2011","unstructured":"Bone HG, Bolognese MA, Yuen CK, et al.. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab. 2011, 96:972-80. 10.1210\/jc.2010-1502","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/354762-bone-mineral-density-and-bone-quality-trends-in-a-child-on-steroid-therapy-who-developed-a-vertebral-fracture-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T05:45:12Z","timestamp":1745214312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/354762-bone-mineral-density-and-bone-quality-trends-in-a-child-on-steroid-therapy-who-developed-a-vertebral-fracture-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.82675","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}